Pharmacology, Toxicology and Pharmaceutical Science
Mouse
80%
Neoplasm
68%
Prostate Cancer
58%
Carcinogenesis
52%
Breast Cancer
50%
Malignant Neoplasm
41%
12-O-Tetradecanoylphorbol-13-Acetate
30%
Overall Survival
27%
Androgen
26%
Atorvastatin
25%
Celecoxib
25%
Pancreas Cancer
24%
Metformin
21%
Disease
20%
Tocopherol
17%
Skin Carcinogenesis
17%
Breast Tumor
15%
Prostate Tumor
14%
Chemotherapy
13%
Acute Myeloid Leukemia
13%
Paclitaxel
13%
Retinoic Acid
12%
Progression Free Survival
12%
Clinical Trial
12%
Comorbidity
12%
Cancer Specific Survival
11%
Colorectal Cancer
11%
Prostate Specific Antigen
11%
Cancer Growth
10%
SCID Mouse
10%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
10%
Statin (Protein)
10%
Pharmacokinetics
9%
Colon Cancer
9%
Epigallocatechin Gallate
9%
Cyclophosphamide
9%
Pancreas Tumor
9%
Maximum Tolerated Dose
8%
Etoposide
8%
DNA Topoisomerase
8%
Burkitt's Lymphoma
8%
Polyphenol
8%
Solid Malignant Neoplasm
8%
Venous Thromboembolism
8%
Imatinib
8%
Chronic Disease
8%
Melanoma
8%
Acetylsalicylic Acid
8%
Zearalenone
8%
Azoxymethane
8%
Keyphrases
Confidence Interval
64%
Tumor
39%
Breast Cancer
30%
Breast Cancer Risk
29%
Inhibitory Effect
27%
Ultraviolet-B (UV-B)
25%
Vitamin E
25%
Overall Survival
25%
Odds Ratio
25%
Prostate Cancer
23%
New Jersey
23%
Phorbol 12-myristate 13-acetate
22%
Clinical Trials
22%
Atorvastatin
21%
Skin Carcinogenesis
21%
Black Women
21%
Prostate-specific Antigen
19%
Caffeine
19%
Single nucleotide Polymorphism
17%
Framingham Offspring Study
17%
Localized Prostate Cancer
17%
Metformin
17%
Celecoxib
17%
Immunodeficient Mice
17%
SKH-1 Hairless Mice
16%
Hazard Ratio
16%
In Cancer
15%
African American Women
14%
Breast Cancer Survivors
14%
National Health Interview Survey
14%
NHANES
14%
Apoptosis
14%
Cancer Risk
13%
United States
13%
Mammary Tumorigenesis
13%
Breast Cancer Mortality
13%
Cancer Genetics Risk Assessment
12%
Pancreatic Cancer Cells
12%
Running Wheel Exercise
12%
Advanced Malignancies
12%
Obesity-related Cancer
12%
All-trans Retinoic Acid
12%
African American
12%
High Risk
12%
Comorbidity
11%
High-fat Diet
11%
Mammary Tumor
11%
Prostate
11%
Single Sperm
11%
Colorectal Cancer
11%
Medicine and Dentistry
Breast Cancer
100%
Malignant Neoplasm
55%
Neoplasm
52%
Prostate Cancer
50%
Overall Survival
34%
Disease
24%
Radiation Therapy
22%
Cancer Diagnosis
22%
Prostate Specific Antigen
19%
Cancer Risk
19%
Odds Ratio
19%
Androgen Deprivation Therapy
18%
Genetic Risk
17%
Breast Tumor
16%
Hazard Ratio
15%
Diabetes
14%
Conservative Treatment
14%
Carcinogenesis
14%
Body Mass Index
13%
Randomized Controlled Trial
13%
Cancer Therapy
13%
DNA Microarray
13%
Acute Myeloid Leukemia
12%
Lung Cancer
12%
Child
12%
Cancer Genetics
12%
Stomach Cancer
12%
Cancer
12%
Obesity
11%
Estrogen Receptor
11%
Arm
11%
Colorectal Cancer
11%
Clinical Trial
11%
Logistic Regression Analysis
11%
Progression Free Survival
10%
Mediator
9%
Surgery
9%
Prognostication
9%
Race Difference
9%
Ethnic Group
9%
Risk Communication
9%
Cardiovascular Disease
9%
Nodular Melanoma
9%
Gene Expression
8%
Ovarian Cancer
8%
Adipocytokine
8%
Burkitt's Lymphoma
8%
Apoplexy
8%
Tumor Microenvironment
8%
Health Care Cost
8%